Early Alert: Microbore Extension Set Issue from B. Braun Medical Inc.

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has become aware of a potentially high-risk issue. The FDA will keep the public informed and update this web page as significant new information becomes available.  Affected Product The FDA is aware that B. Braun Medical Inc. has…

Early Alert: Infusion Set Performance Issue from BD

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has become aware of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. Affected Product The FDA is aware that BD and their subsidiary…

Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Sucralfate Tablets USP 1 Gram Within Expiry

Summary Company Announcement Date: July 11, 2025 FDA Publish Date: July 14, 2025 Product Type: Drugs Reason for Announcement: Recall Reason Description Company closure and discontinuation of quality activities. Company Name: Nostrum Laboratories, Inc. Brand Name: Brand Name(s) Nostrum Laboratories Product Description: Product Description Sucralfate Tablets USP 1 gram Company Announcement NEW YORK, DC, UNITED…

Extended-Release Stimulants for ADHD: FDA Drug Safety Communication – FDA Requires Expanded Labeling about Weight Loss Risk in Patients Younger than 6 Years

AUDIENCE: Patient, Health Care Professional, Pharmacy, Pediatrics ISSUE: The FDA is revising the labeling of all extended-release stimulants indicated to treat attention-deficit/hyperactivity disorder (ADHD) – including certain formulations of amphetamine and methylphenidate – to warn about the risk of weight loss and other adverse reactions (side effects) in patients younger than 6 years taking these…

Early Alert: Blood Pump Controller Issue from Abiomed

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has become aware of a potentially high-risk issue. The FDA will keep the public informed and update this web page as significant new information becomes available.  Affected Product The FDA is aware that Abiomed has issued a letter…

Early Alert: Infusion Pump Software Issue from Baxter

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has become aware of a potentially high-risk issue. The FDA will keep the public informed and update this web page as significant new information becomes available.  Affected Product  Spectrum V6 infusion pump startup screen Spectrum V8 infusion pump…